Fermo Elisa, Trombetta Elena, Marcello Anna Paola, Vercellati Cristina, Ferrari Giulia Maria, Zaninoni Anna, Brancaleoni Valentina, Di Pierro Elena, Beneventi Sara, Tornese Marta, Fattizzo Bruno, Casini Tommaso, Corti Paola, Bianchi Paola
Hematology, Physiopathology of Anemia Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.
Flow Cytometry Service, Clinical Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.
Int J Mol Sci. 2025 Aug 10;26(16):7722. doi: 10.3390/ijms26167722.
Adenosine Triphosphatase (ATPase) Phospholipid Transporting 11C gene (), located on the X chromosome, encodes the major phosphatidylserine flippase in human erythroid cells. Only five patients have so far been reported with defective , displaying mild hemolytic anemia and reduced flippase activity. In this study, we report four Italian male patients in three unrelated families with novel private mutations in the gene, resulting in impaired flippase activity associated with mild/compensated hemolytic anemia. The decreased flippase activity was measured as % of phosphatidylserine internalization over time and ranged after 20 min incubation from 5% to 18.6% in all patients, regardless of the type of molecular defect. Flippase activity was also tested in healthy controls, ranging from 43% to 62% in both males and females. This measurement appears to be a useful tool for hypothesizing abnormalities in male subjects with mild compensated hemolysis, prior to next generation sequencing (NGS) analysis. Although rare, mutations may be underrecognized, and therefore should be suspected and investigated in male patients presenting with subtle hemolytic signs or symptoms.
位于X染色体上的三磷酸腺苷酶(ATPase)磷脂转运11C基因(),编码人类红细胞中的主要磷脂酰丝氨酸翻转酶。迄今为止,仅报道了5例该基因缺陷患者,表现为轻度溶血性贫血和翻转酶活性降低。在本研究中,我们报告了来自三个无关家庭的4名意大利男性患者,他们的该基因存在新的私人突变,导致翻转酶活性受损,并伴有轻度/代偿性溶血性贫血。翻转酶活性降低通过磷脂酰丝氨酸内化随时间的百分比来衡量,在所有患者中,孵育20分钟后,无论分子缺陷类型如何,该百分比范围为5%至18.6%。还对健康对照进行了翻转酶活性测试,男性和女性的活性范围为43%至62%。在进行下一代测序(NGS)分析之前,这种测量似乎是一种有用的工具,可用于推测轻度代偿性溶血男性受试者中的异常情况。尽管罕见,但该基因突变可能未被充分认识,因此对于出现轻微溶血体征或症状的男性患者应怀疑并进行调查。